Funds holding “Arcus Biosciences Inc”
Which closed-end funds own a security? Searches the latest N-PORT snapshot of every active fund. Enter a ticker (issuer-level: matches the vendor-mapped ticker), a CUSIP or ISIN (security-level: one specific bond or share class), or part of a name.
7 positions across 7 funds. Weights are percent of net assets from each fund’s latest N-PORT; report dates differ by fund.
| Fund | Position | Identifier | Type | Weight | Value (USD) | Report date | Coverage |
|---|---|---|---|---|---|---|---|
| HQL abrdn Life Sciences Investors Healthcare | Arcus Biosciences Inc | 03969F109 | EC | 0.69% | $4.8M | Jun 30, 2026 | full (145 positions) |
| THQ abrdn Healthcare Opportunities Fund Healthcare | Arcus Biosciences Inc | 03969F109 | EC | 0.61% | $6.4M | Jun 30, 2026 | full (109 positions) |
| BMEZ BlackRock Health Sciences Term Trust Healthcare | Arcus Biosciences Inc | 03969F109 | EC | 0.55% | $6M | Jun 30, 2026 | full (170 positions) |
| HQH abrdn Healthcare Investors Healthcare | Arcus Biosciences Inc | 03969F109 | EC | 0.51% | $7M | Jun 30, 2026 | full (154 positions) |
| BME BlackRock Health Sciences Trust Healthcare | Arcus Biosciences Inc | 03969F109 | EC | 0.28% | $1.6M | Jun 30, 2026 | full (152 positions) |
| GUG Guggenheim Active Allocation Fund U.S. Equity | ARCUS BIOSCIENCES INC | 03969F109 | EC | 0.00% | $13.3K | May 29, 2026 | full (1,258 positions) |
| QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund Covered Call / Option Income | Arcus Biosciences Inc | 03969F109 | EC | 0.00% | $24.8K | Jun 30, 2026 | full (228 positions) |
Matching position names
Historical holdings reports are not a real-time portfolio. Security-level matching (CUSIP/ISIN) distinguishes a company’s bonds, common shares, preferreds and derivatives; issuer-level matching groups them by name or ticker and is labelled as such. See the overlap tool to compare two portfolios.